Functions of the VEGF receptor-1 (FLT-1) in the vasculature

Trends in Cardiovascular Medicine

Volumn 8, Issue 6, 1998, Pages 241-245

  Clauss, Matthias ^a  

^a MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR; PROCOAGULANT; TYROSINE KINASE RECEPTOR; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR; VASCULOTROPIN RECEPTOR 1;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ATHEROSCLEROSIS; CELL MIGRATION; CORONARY ARTERY OBSTRUCTION; DIABETIC RETINOPATHY; ENDOTHELIUM CELL; ENZYME ACTIVITY; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR UPREGULATION; SHORT SURVEY;

EID: 0031695198     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1050-1738(98)00015-2     Document Type: Article

References (59)

1. Adamis AP, Miller JW, Bernal MT, et al.: 1994. Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol 118:445-450.
2. Ahmed A, Dunk C, Kniss D, Wilkes M: 1997. Role of VEGF receptor-1 (Flt-1) in mediating calcium-dependent nitric oxide release and limiting DNA synthesis in human trophoblast cells. Lab Invest 76:779-791.
3. Aiello LP, Pierce EA, Foley ED, Takagi H, Chen H: 1995. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Proc Natl Acad Sci USA 92:10457-10461.
4. Arras M, Ito W, Scholz D, Winkler B, Schaper J, Schaper W: 1998. Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb. J Clin Invest 101:40-50.
5. Banai S, Jaklitsch MT, Shou M, et al.: 1994. Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs. Circulation 89:2183-2189.
6. Barleon B, Sozanni S, Zhou D, Weich HA, Mantovani A, Marme D: 1996. Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood 87:3336-3343.
7. Bauters C, Asahara T, Zheng LP, et al.: 1995. Recovery of disturbed endothelium-dependent flow in the collateral-perfused rabbit ischemic hindlimb after administration of vascular endothelial growth factor. Circulation 91:2802-2809.
8. Breier G, Clauss M, Risau W: 1995. Coordinate expression of vascular endothelial growth factor receptor-1 (flt-1) and its ligand suggest a paracrine regulation of murine vascular development. Dev Dynamics 204:228-239.
9. Brock TA, Dvorak HF, Senger DR: 1991. Tumor-secreted vascular-permeability factor increases cytosolic Ca2+ and von Willebrand-factor release in human endothelial cells. Am J Pathol 138:213-221.
10. Broxmeyer HE, Cooper S, Li ZH, et al.: 1995. Myeloid progenitor cell regulatory effects of vascular endothelial cell growth factor. Int J Hematol 62:203-215.
11. Cao Y, Chen H, Zhou L, et al.: 1995. Heterodimers of placenta growth factor/vascular endothelial growth factor. J Biol Chem 271:3154-3162.
12. Carmeliet P, Ferreira V, Breier G, et al.: 1996. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380:435-439.
13. Clauss M, Gerlach M, Gerlach H, et al.: 1990. Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration. J Exp Med 172:1535-1545.
14. Clauss M, Weich H, Breier G, et al.: 1996. The vascular endothelial growth factor receptor flt-1 mediates biological activities: implications for a functional role of placenta growth factor in monocyte activation and chemotaxis. J Biol Chem 271:17629-17634.
15. Colotta F, Re F, Muzio M, et al.: 1993. Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4. Science 261:472-475.
16. Couffinhal T, Kearney M, Witzenbichler B, et al.: 1997. Vascular endothelial growth factor/vascular permeability factor (VEGF/ VPF) in normal and atherosclerotic human arteries. Am J Pathol 150:1673-1685.
17. De Vries C, Escobedo JA, Ueno H, Houck K, Ferrara N, Williams LT: 1992. The fms-like tyrosine kinase, a receptor for vascular endothelial growth-factor. Science 255: 989-991.
18. Dor Y, Keshet E: 1997. Ischemia-driven angiogenesis. Trends Cardiovasc Med 7:289-294.
19. Dvorak HF: 1986. Tumors: wounds that do not heal. Similarities between tumor stroma formation and wound healing. N Engl J Med 315:1650-1658.
20. Fong GH, Rossant J, Gertsenstein M, Breitman ML: 1995. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 376:66-70.
21. Fulton WFM: 1965. The Coronary Arteries. Springfield, IL, Thomas, C.C.
22. Gabrilovich DI, Chen HL, Girgis KR, et al.: 1996. Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dentritic cells. Nature Med 2:1096-1103.
23. Harada K, Friedman M, Lopez JJ, et al.: 1996. Vascular endothelial growth factor administration in chronic myocardial ischemia. Am J Physiol 270:H1791-H1802.
24. Ito W, Arras M, Winkler B, Scholz D, Schaper J, Schaper W: 1997. Monocyte chemotactic protein-1 increases collateral and peripheral conductance after femoral artery occlusion. Circ Res 80:829-837.
25. Kendall RL, Wang G, DiSalvo J, Thomas KA: 1994. Specificity of vascular endothelial growth factor receptor binding domains. Biochem Biophys Res Commun 201:326-330.
26. Kim KJ, Li B, Winer J, Armanini M, Gillett N, Phillips HS, Ferrara N: 1993. Inhibition of vascular endothelial growth factor induced angiogenesis suppresses tumor growth in vivo. Nature 362:841-844.
27. Knighton DR, Hunt TK, Scheienstuhl H, Haliday BJ, Werb Z, Banda MJ: 1983. Oxigen tension regulates the expression of angiogenesis factor by macrophages. Science 221:1283-1285.
28. Kukk E, Lymboussaki A, Taira S, et al.: 1996. VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development. J Biol Chem 271:1270-1273.
29. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N: 1989. Vascular endothelial growth-factor is a secreted angiogenic mitogen. Science 246:1306-1309.
30. Maglione D, Guerriero V, Viglietto G, Delli-Bovi P, Persico MG: 1991. Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proc Natl Acad Sci USA 88:9267-9271.
31. Millauer B, Wizigmann-Voos S, Schnürch H, et al.: 1993. High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 72:835-846.
32. Millauer B, Shawver L, Plate KH, Risau W, Ullrich A: 1994. Glioblastoma growth inhibited in vivo by a dominant-negative flk-1 mutant. Nature 367:576-579.
33. Olander JV, Connolly DT, DeLarco JE: 1991. Specific binding of vascular permeability factor to endothelial cells. Biochem Biophys Res Commun 175:68-76.
34. Park JE, Chen HH, Winer H, Houck KA, Ferrara N: 1994. Placenta growth factor: potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to flt-1 but not to Flk-1/ KDR. J Biol Chem 269:25646-25654.
35. Pearlman JD, Hibberd MG, Chuang ML, et al.: 1995. Magnetic resonance mapping demonstrates benefits of VEGF-induced myocardial angiogenesis. Nature Med 1: 1085-1089.
36. Pekala P, Marlow M, Heuvelmann D, Connolly D: 1990. Regulation of hexose transport in aortic endothelial cells by vascular permeability factor and tumor necrosis factor-alpha, but not by insulin. J Biol Chem 265:18051-18054.
37. Pepper MS, Ferrara N, Orci L, Montesano R: 1991. Vascular endothelial growth-factor (VEGF) induces plasminogen activators and plasminogen-activator inhibitor-1 in microvascular endothelial-cells. Biochem Biophys Res 181:902-906.
38. Risau W: 1997. Mechanisms of angiogenesis. Nature 386:671-674.
39. Roberts WG, Palade GE: 1995. Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J Cell Sci 108:2369-2379.
40. Rollins BJ: 1996. Monocyte chemoattractant protein 1: a potential regulator of monocyte recruitment in inflammatory disease. Mol Med Today 2:198-204.
41. Sawano A, Takahashi T, Yamaguchi S, Aonuma M, Shibuya M: 1996. Flt-1 but not KDR/Flk-1 tyrosine kinase is a receptor for placenta growth factor, which is related to vascular endothelial growth factor. Cell Growth Differ 7:213-221.
42. Schaper W, Ito W: 1996. Molecular mechanisms of coronary collateral vessel growth. Circ Res 79:911-919.
43. Seetharam L, Gotoh N, Maru Y, Neufeld G, Yamaguchi S, Shibuya M: 1995. A unique signal transduction from Fit tyrosine kinase, a receptor for vascular endothelial growth factor VEGF. Oncogene 10:135-147.
44. Sellke FW, Wang SY, Friedman M, et al.: 1995. Beta-adrenergic modulation of the collateral-dependent coronary microcirculation. J Surg Res 59:185-190.
45. Senger D, Galli S, Dvorak A, Peruzzi C, Harvey V, Dvorak HF: 1983. Vascular permeability factor. Science 219:983-986.
46. Shalaby F, Rossant J, Yamaguchi TP, et al.: 1995. Failure of blood-island formation and vasculogenesis in FIk-1-deficient mice. Nature 376:62-66.
47. Sharma HS, Wunsch M, Brand T, Verdouw PD, Schaper W: 1992. Molecular-biology of the coronary vascular and myocardial responses to ischemia. J Cardiovasc Pharm 20:23-31.
48. Shen H, Clauss M, Ryan J, et al.: 1993. Characterization of vascular-permeability factor/ vascular endothelial growth-factor receptors on mononuclear phagocytes. Blood 81: 2767-2773.
49. Stavri GT, Hong Y, Zachary IC, et al.: 1995. Hypoxia and platelet-derived growth factor synergistically upregulate the expression of vascular endothelial growth factor in vascular smooth muscle cells. FEBS Lett 358: 311-315.
50. Stein I, Neeman M, Shweiki D, Itin A, Keshet E: 1995. Stabilization of vascular endothelial growth factor mRNA by hypoxia and hypoglycemia and coregulation with other ischemia-induced genes. Mol Cell Biol 15:5363-5368.
51. Takahashi T, Shibuya M: 1997. The 230 kDa mature form of KDR/Flk-1 (VEGF receptor-2) activates the PLC-gamma pathway and partially induces mitotic signals in NIH3T3 fibroblasts. Oncogene 14:2079-2089.
52. Takeshita S, Zheng LP, Brogi E, et al.: 1994. Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. J Clin Invest 93:662-670.
53. Takeshita S, Weir L, Chen D, et al.: 1996. Therapeutic angiogenesis following arterial gene transfer of vascular endothelial growth factor in a rabbit model of hind-limb ischemia. Biochem Biophys Res Comm 227:628-635.
54. Tian H, McKnight SL, Russel DW: 1997. Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells. Genes Develop 11:72-82.
55. Waltenberger J, Claesson-Welsh L, Siegbahn A, Shibuya M, Heldin C-H: 1994. Different signal transduction properties of KDR and flt1, two receptors for vascular endothelial growth factor. J Biol Chem 269:26988-26995.
56. Ware JA, Simons M: 1997. Angiogenesis in ischemic heart disease. Nature Med 3:158-164.
57. Wilcox JN, Nelken NA, Coughlin SR, Gordon D, Schall TJ: 1994. Local expression of inflammatory cytokines in human atherosclerotic plaques. J Atheroscl Thromb (Suppl 1):10-13.
58. Wu MH, Huang Q, Yuan Y, Granger HJ: 1996. VEGF induces NO-dependent hyperpermeability in coronary venules. Am J Physiol H271:H2735-2739.
59. Ziche M, Maglione D, Ribatti D, et al.: 1997. Placenta growth factor-1 is chemotactic, mitogenic, and angiogenic. Lab Invest 76:517-531.